DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Thymoglobulin (Anti-Thymocyte Globulin) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (368)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thymoglobulin (Anti-Thymocyte Globulin) death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 368   Next >>

Possible Thymoglobulin side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-24

Patient: male, weighing 73.0 kg (160.6 pounds)

Reactions: Enterococcal Bacteraemia, Lower Respiratory Tract Infection Bacterial, Respiratory Distress, Myopathy, Ascites, Graft Versus Host Disease in Skin, Lower Respiratory Tract Infection Viral, Rash Erythematous, Hypoalbuminaemia, Abdominal Distension, Lung Infiltration, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Thymoglobulin
    Dosage: 2 mg/kg, once
    Start date: 2012-01-04
    End date: 2012-01-04

Thymoglobulin
    Dosage: 0.5 mg/kg, once
    Indication: Prophylaxis Against Graft Versus Host Disease
    Start date: 2012-01-03
    End date: 2012-01-03

Thymoglobulin
    Dosage: 2 mg/kg, once
    Start date: 2012-01-06
    End date: 2012-01-06



Possible Thymoglobulin side effects in 64 year old female

Reported by a physician from Japan on 2012-08-23

Patient: 64 year old female

Reactions: Death

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Thymoglobulin



Possible Thymoglobulin side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 25.0 kg (55.0 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Hypertension, Fusarium Infection

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Clolar
    Dosage: 70 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: 254 mg, qd
    Start date: 2012-06-16
    End date: 2012-06-19

Thymoglobulin
    Dosage: 229.9 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Other drugs received by patient: Meropenem; Fentanyl Citrate; Cytarabine; Thiotepa; Melphalan Hydrochloride; Dilaudid; Busulfan



Possible Thymoglobulin side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-21

Patient: female, weighing 115.0 kg (253.0 pounds)

Reactions: Bronchopulmonary Aspergillosis, Multi-Organ Failure, Cytomegalovirus Viraemia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Thymoglobulin
    Dosage: 2 mg/kg, qd
    Start date: 2011-04-16
    End date: 2011-04-16

Thymoglobulin
    Dosage: 2 mg/kg, qd
    Start date: 2011-04-19
    End date: 2011-04-19

Thymoglobulin
    Dosage: 0.5 mg/kg, qd
    Indication: Prophylaxis Against Graft Versus Host Disease
    Start date: 2011-04-15
    End date: 2011-04-15

Other drugs received by patient: Voriconazole; Cyclosporine; Ganciclovir



Possible Thymoglobulin side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 25.0 kg (55.0 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Clolar
    Dosage: 70 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: 229.9 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Thymoglobulin
    Dosage: 254 mg, qd
    Start date: 2012-06-16
    End date: 2012-06-19

Other drugs received by patient: Busulfan; Thiotepa; Dilaudid; Meropenem; Cytarabine; Melphalan Hydrochloride; Fentanyl Citrate



Possible Thymoglobulin side effects in male

Reported by a physician from Japan on 2012-08-21

Patient: male, weighing 75.0 kg (165.0 pounds)

Reactions: Respiratory Disorder, Atrial Fibrillation, Pyrexia, Abdominal Pain Upper, Hypokalaemia, Arrhythmia, Therapeutic Response Decreased, Blood Calcium Decreased, Renal Impairment, Face Oedema, Palpitations, Oedema Peripheral, Aplastic Anaemia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Thymoglobulin

Other drugs received by patient: Entecavir; Biapenem; Prednisolone; Dexchlorpheniramine Maleate; Spironolactone; Methylprednisolone Sodium Succinate; Filgrastim; Sulbactam Sodium Cefoperazone Sodium; Arbekacin Sulfate; Teprenone; Biapenem; Cefozopran Hydrochloride; Fluconazole; Rabeprazole Sodium; Deferasirox; Filgrastim; Biapenem; Amino Acids; Entecavir; Filgrastim; Pepsin Treated Human Immunoglobulin; Sulfamethoprim; Deferasirox; Filgrastim; Furosemide; Cefozopran Hydrochloride; Itraconazole



Possible Thymoglobulin side effects in male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-21

Patient: male, weighing 110.0 kg (242.0 pounds)

Reactions: Transplant Failure, Atelectasis, Blood Bilirubin Increased, White Blood Cell Count Decreased, Dyspnoea, Pyrexia, Venoocclusive Liver Disease, Sepsis, Pleural Effusion, Blood Creatinine Increased, Cardiac Arrest

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Thymoglobulin
    Dosage: 0.5 mg/kg, once
    Indication: Prophylaxis Against Graft Versus Host Disease
    Start date: 2011-08-24
    End date: 2011-08-24

Thymoglobulin
    Dosage: 2 mg/kg, once
    Start date: 2011-08-27
    End date: 2011-08-27

Thymoglobulin
    Dosage: 2 mg/kg, once
    Indication: Immunosuppression
    Start date: 2011-08-25
    End date: 2011-08-25

Other drugs received by patient: Fluconazole; Folic Acid; Acyclovir; Lasix; NPH Insulin; Cyclosporine; Fentanyl Citrate; Humulin N; Ursodiol; Midazolam; Insulin Toronto



Possible Thymoglobulin side effects in male

Reported by a physician from Japan on 2012-08-20

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Pneumonia, Lung Adenocarcinoma, Cardiac Failure, Oedema Peripheral, Aplastic Anaemia, Neutrophil Count Decreased, Pharyngitis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclosporine
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-12-01
    End date: 2010-03-17

Thymoglobulin
    Dosage: 262.5 mg, qd
    Indication: Aplastic Anaemia
    Start date: 2009-12-09
    End date: 2009-12-13

Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Diazepam; Omeprazole; Polaprezinc; Fluconazole; Deferasirox



Possible Thymoglobulin side effects in 4 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-17

Patient: 4 year old male

Reactions: Acute Graft Versus Host Disease

Adverse event resulted in: death

Drug(s) suspected as cause:
Busulfan
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Cyclophosphamide
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Thymoglobulin
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Other drugs received by patient: Methotrexate; Cyclosporine



Possible Thymoglobulin side effects in female

Reported by a physician from Japan on 2012-08-17

Patient: female, weighing 13.0 kg (28.6 pounds)

Reactions: Vomiting, Pneumonia, Cytomegalovirus Test Positive, Escherichia Urinary Tract Infection, Pyrexia, Staphylococcal Sepsis, Epstein-Barr Virus Infection, Pulmonary Haemorrhage, Bacterial Infection, Acute Respiratory Distress Syndrome

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Fludara
    Dosage: 15 mg/m2, qd (4 days); injection
    Indication: Aplastic Anaemia
    Start date: 2011-04-15
    End date: 2011-04-18

Thymoglobulin
    Indication: Aplastic Anaemia

Thymoglobulin
    Dosage: 33 mg, qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2011-04-15
    End date: 2011-04-18

Other drugs received by patient: Fluconazole; Acyclovir; Sulfamethoprim; Cyclophosphamide; Platelets; Hydroxyzine Pamoate; Human RED Blood Cells; Cyclosporine; Methylprednisolone Sodium Succinate



Possible Thymoglobulin side effects in 37 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-17

Patient: 37 year old male

Reactions: Graft Versus Host Disease

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Thymoglobulin
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Other drugs received by patient: Methotrexate; Cyclosporine



Possible Thymoglobulin side effects in 66 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-17

Patient: 66 year old male, weighing 60.0 kg (132.0 pounds)

Reactions: Haemoptysis, Cytomegalovirus Test Positive, Interstitial Lung Disease, Acute Graft Versus Host Disease in Skin, Disseminated Intravascular Coagulation, Pyrexia, Necrotising Oesophagitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Thymoglobulin
    Dosage: 77.5 mg, qd
    Indication: Prophylaxis
    Start date: 2011-06-17
    End date: 2011-06-17

Thymoglobulin
    Dosage: 72.5 mg, qd
    Indication: Acute Graft Versus Host Disease
    Start date: 2011-07-05
    End date: 2011-07-05

Other drugs received by patient: Busulfan; Micafungin Sodium; Fosfomycin Calcium; Fludarabine Phosphate; Cefepime Hydrochloride; Methylprednisolone Sodium Succinate; Tacrolimus; Acyclovir; Micafungin Sodium; Mycophenolate Mofetil; Doripenem Hydrate; Doripenem Hydrate; Lenograstim



Possible Thymoglobulin side effects in 1 year old female

Reported by a physician from Japan on 2012-08-17

Patient: 1 year old female

Reactions: Graft Versus Host Disease

Adverse event resulted in: death

Drug(s) suspected as cause:
Busulfan
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Cyclophosphamide
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Thymoglobulin
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Other drugs received by patient: Methotrexate; Cyclosporine



Possible Thymoglobulin side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female, weighing 25.2 kg (55.4 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Thymoglobulin
    Dosage: unk
    Start date: 2012-06-16
    End date: 2012-06-19

Other drugs received by patient: Melphalan Hydrochloride; Busulfan; Fentanyl; Thiotepa; Cytarabine; Dilaudid; Meropenem



Possible Thymoglobulin side effects in female

Reported by a physician from Japan on 2012-08-15

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Acute Graft Versus Host Disease, Urinary Tract Infection, Acute Myeloid Leukaemia, Sepsis, Cytomegalovirus Viraemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Thymoglobulin

Other drugs received by patient: Fludarabine Phosphate; Tacrolimus; Methotrexate; Cefepime Hydrochloride; Methylprednisolone; Busulfan; Acyclovir; Cotrim



Possible Thymoglobulin side effects in female

Reported by a physician from Japan on 2012-08-15

Patient: female, weighing 37.0 kg (81.4 pounds)

Reactions: Multi-Organ Failure, Disseminated Intravascular Coagulation, Bacterial Infection, Meningitis, Thrombotic Microangiopathy

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Thymoglobulin

Other drugs received by patient: Ganciclovir; Carbenin; Tacrolimus; Fludara; Methotrexate; Acyclovir; Cefazolin Sodium; Micafungin Sodium; Filgrastim; Cyclophosphamide; Lenograstim; Methylprednisolone Sodium Succinate



Possible Thymoglobulin side effects in female

Reported by a physician from Japan on 2012-08-15

Patient: female, weighing 59.0 kg (129.8 pounds)

Reactions: Otitis Media, Aplastic Anaemia, Anal Haemorrhage

Adverse event resulted in: death

Drug(s) suspected as cause:
Thymoglobulin

Other drugs received by patient: Methylprednisolone Sodium Succinate; Cyclosporine; Metenolone Acetate



Possible Thymoglobulin side effects in 12 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-14

Patient: 12 year old female

Reactions: Acute Graft Versus Host Disease

Adverse event resulted in: death

Drug(s) suspected as cause:
Fludara
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Melphalan Hydrochloride
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Therapeutic Radiopharmaceuticals
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Thymoglobulin
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Other drugs received by patient: Cyclosporine



Possible Thymoglobulin side effects in male

Reported by a physician from Japan on 2012-08-14

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Pulmonary Haemorrhage, Acute Respiratory Distress Syndrome, Aplastic Anaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Thymoglobulin

Other drugs received by patient: Platelets; Filgrastim; Antihistamines; Tranexamic Acid; Fluconazole; Ciprofloxacin Hydrochloride; Cyclosporine; Omeprazole; Solu-Medrol; Sulfamethoprim; Adrenocortical Hormone; Amphotericin B; Polaramine; Polaramine



Possible Thymoglobulin side effects in female

Reported by a physician from Japan on 2012-08-13

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Cytomegalovirus Test Positive, Haematuria, Thrombotic Microangiopathy, Post Transplant Lymphoproliferative Disorder, Viral Haemorrhagic Cystitis, Interstitial Lung Disease, Acute Graft Versus Host Disease in Skin, Sepsis

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Fludara
    Dosage: 30 mg/m2, qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-06-03
    End date: 2012-06-08

Thymoglobulin
    Dosage: 50 mg, qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2010-06-09
    End date: 2010-06-10

Other drugs received by patient: Phenobarbital TAB; Clobazam; Teicoplanin; Cytarabine; Lansoprazole; Tacrolimus; Acyclovir; Imipenem; Furosemide; Voriconazole; Roxithromycin; Mycophenolate Mofetil; Foscarnet Sodium; Thrombomodulin Alfa; Acyclovir; Miconazole Nitrate; Cefepime Hydrochloride; Lenograstim; Methylprednisolone; Famotidine; Risperidone; Diazepam; Meropenem; Omeprazole; Prednisone TAB; Filgrastim; Ursodiol; Fluconazole; Valacyclovir Hydrochloride; Micafungin Sodium; Antithrombin III Human; Grenol; Amphotericin B; Zosyn; Melphalan Hydrochloride; Heparin; Tacrolimus; Dopamine HCL



Possible Thymoglobulin side effects in female

Reported by a physician from United States on 2012-08-13

Patient: female, weighing 25.2 kg (55.4 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Thymoglobulin
    Dosage: unk
    Start date: 2012-06-16
    End date: 2012-06-19

Other drugs received by patient: Meropenem; Melphalan Hydrochloride; Cytarabine; Busulfan; Dilaudid; Fentanyl; Thiotepa



Possible Thymoglobulin side effects in

Reported by a physician from Germany on 2012-08-13

Patient:

Reactions: Multi-Organ Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Thymoglobulin



Possible Thymoglobulin side effects in female

Reported by a physician from Japan on 2012-08-13

Patient: female, weighing 48.0 kg (105.6 pounds)

Reactions: Stomatitis, Supraventricular Tachycardia, Shock Haemorrhagic, Disseminated Intravascular Coagulation, Endotoxaemia, Febrile Neutropenia, Pyrexia, Hypokalaemia, Venoocclusive Disease, Hypoalbuminaemia, Oedema, Neutropenia, Engraft Failure, Antithrombin III Decreased, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Fludara
    Dosage: 20 mg, qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2011-09-13
    End date: 2011-09-17

Thymoglobulin
    Dosage: 60 mg, qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2011-09-18
    End date: 2011-09-19

Other drugs received by patient: Azasetron Hydrochloride; Antibiotics-Resistant Lactic Acid Bacteriae; Dexchlorpheniramine Maleate; Rebamipide; Aprepitant; Itraconazole; Lansoprazole; Allopurinol; Acyclovir; Methylprednisolone Sodium Succinate; Polymyxin B Sulfate; Sulfamethoprim; Acetaminophen; Clostridium Butyricum; Acetaminophen; Lansoprazole; Cyclosporine; Dalteparin Sodium; Itraconazole; Melphalan Hydrochloride; Methotrexate



Possible Thymoglobulin side effects in

Reported by a physician from Germany on 2012-08-13

Patient:

Reactions: Multi-Organ Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Thymoglobulin



Possible Thymoglobulin side effects in 44 year old female

Reported by a physician from United States on 2012-08-10

Patient: 44 year old female

Reactions: Device Related Sepsis, Enterococcal Infection, Transplant Rejection, Calciphylaxis, Mesenteric Haemorrhage, Colonic Fistula, Impaired Healing, Sepsis, Blood Creatinine Increased, Escherichia Infection, Asthenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Immunoglobulins NOS
    Dosage: unk

Immunoglobulins NOS
    Dosage: 0.5 mg/kg, cyclic
    Indication: Prophylaxis Against Transplant Rejection

Methylprednisolone
    Dosage: 500 mg, unk

Methylprednisolone
    Dosage: 125 mg, cyclic
    Indication: Prophylaxis Against Transplant Rejection

Mycophenolate Mofetil
    Dosage: 1 g, unk

Mycophenolate Mofetil
    Dosage: 500 mg, bid
    Indication: Prophylaxis Against Transplant Rejection

Tacrolimus
    Dosage: unk
    Indication: Prophylaxis Against Transplant Rejection

Thymoglobulin
    Dosage: 1.25 unk, unk

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Prophylaxis Against Transplant Rejection

Other drugs received by patient: Prednisone TAB; Rituximab



Possible Thymoglobulin side effects in male

Reported by a physician from Japan on 2012-08-10

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Acute Graft Versus Host Disease, Hepatic Failure, Acute Graft Versus Host Disease in Liver

Adverse event resulted in: death

Drug(s) suspected as cause:
Thymoglobulin

Other drugs received by patient: Tacrolimus; Busulfan; Itraconazole; Fludarabine Phosphate; Methylprednisolone; Cefozopran Hydrochloride; Etoposide; Melphalan Hydrochloride; Acyclovir



Possible Thymoglobulin side effects in male

Reported by a physician from Japan on 2012-08-09

Patient: male, weighing 60.0 kg (132.0 pounds)

Reactions: Renal Disorder, Cardiac Failure, Sepsis, Hypertension, Liver Disorder

Adverse event resulted in: death

Drug(s) suspected as cause:
Thymoglobulin

Other drugs received by patient: Ketamine HCL; Acyclovir; Albumin (Human); Immune Globulin (Human); Hydrocortisone Sodium Succinate; Morphine HCL Elixir; Dalteparin Sodium; Azasetron Hydrochloride; Concentrated Glycerine Fructose; Cidofovir; Dexamethasone; Cefozopran Hydrochloride; Methylprednisolone Sodium Succinate; Probenecid



Possible Thymoglobulin side effects in male

Reported by a physician from Japan on 2012-08-08

Patient: male, weighing 68.0 kg (149.6 pounds)

Reactions: Aplastic Anaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Thymoglobulin

Other drugs received by patient: Cyclosporine



Possible Thymoglobulin side effects in male

Reported by a physician from Japan on 2012-08-02

Patient: male, weighing 58.0 kg (127.6 pounds)

Reactions: Circulatory Collapse, Escherichia Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Thymoglobulin



Possible Thymoglobulin side effects in female

Reported by a physician from Japan on 2012-07-31

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Lymphadenopathy, Pruritus, Disseminated Intravascular Coagulation, Pyrexia, Erythema, Abdominal Discomfort, Graft Versus Host Disease in Skin, Unevaluable Event, Melaena, Epistaxis, Blister, Metabolic Acidosis, Pneumonia, Mouth Haemorrhage, Urine Output Decreased, Pleurisy, General Physical Health Deterioration, Staphylococcal Sepsis, Post Transplant Lymphoproliferative Disorder, Septic Shock, Eye Discharge, Shock Haemorrhagic, Oral Herpes, Electrolyte Depletion, Conjunctival Hyperaemia, Pleural Effusion, Blood Glucose Increased, Renal Failure Acute, Stevens-Johnson Syndrome, White Blood Cell Count Decreased, Vomiting, Excoriation, Ascites, Vulvar Erosion, Diarrhoea, Skin Erosion, Blood Pressure Decreased, Eyelid Erosion

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Allopurinol
    Dosage: unk
    Indication: Prophylaxis
    Start date: 2011-06-23
    End date: 2011-06-29

Corticosteroid NOS
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Fludara
    Dosage: 40 mg, qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2011-02-13
    End date: 2011-02-16

Thymoglobulin
    Dosage: 115 mg, qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2011-02-11
    End date: 2011-02-12

Other drugs received by patient: Cyclophosphamide; Fludarabine Phosphate; Prednisolone; Potassium Chloride; Magnesium Sulfate; Moxifloxacin Hydrochloride; Sulfamethoprim; Magnesium Oxide; Tacrolimus; Acyclovir; Mycophenolate Mofetil; Carbazochrome Sodium Sulfonate; Hydroxyzine Pamoate; Fentanyl Citrate; Rocuronium Bromide; RED Blood Cells, Concentrated; Micafungin Sodium; Granisetron Hydrochloride; Ursodiol; Sodium Bicarbonate; Rebamipide; Aciphex; Hydrocortisone Sodium Succinate; Omeprazole; Midazolam; Levofloxacin; Methylprednisolone Sodium Succinate; Dexchlorpheniramine Maleate; Ramosetron Hydrochloride; Platelets; Acetaminophen; Hydrocortisone Sodium Succinate; Lansoprazole; Valacyclovir Hydrochloride; Propofol; Mesna; Furosemide; Hydroxyzine Pamoate; Dexmedetomidine Hydrochloride



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017